Evidence map›Paper›PMID 28507921›Full record

ArticleJournal of clinical and translational hepatology2017

Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States.

Channa R Jayasekera, Rachel Beckerman, Nathaniel Smith, Ryan B Perumpail, Robert J Wong, Zobair M Younossi, Aijaz Ahmed

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. A Guide to the Economics of Hepatitis C Virus Cure in 2017.Infectious disease clinics of North America · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Channa R JayasekeraLiver Transplant Program, Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA.
Rachel BeckermanMaple Health Group, LLC, New York, New York, USA.
Nathaniel SmithMaple Health Group, LLC, New York, New York, USA.
Ryan B PerumpailLiver Transplant Program, Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA.
Robert J WongDivision of Gastroenterology and Hepatology, Alameda Health System, Highland Hospital, Oakland, California, USA.
Zobair M YounossiDepartment of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, Virginia, USA.
Aijaz AhmedLiver Transplant Program, Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA.
Center for Innovation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cost effectivenessHepatitis CTask shiftingTreatment access

Identifiers

PMID28507921
PMCPMC5411351
OpenAlexW2583810409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.